Medicinova (MNOV) Other Non Operating Income (2010 - 2025)
Medicinova's (MNOV) quarterly Other Non Operating Income came in at $27236.0 in Q4 2025, down 94.11% year-on-year from $462050.0 in Q4 2024, and up 366.37% on a QoQ basis from -$10225.0 in Q3 2025.
Medicinova (MNOV) Other Non Operating Income (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Other Non Operating Income data on file, last reported at $27236.0 in Q4 2025.
- On a quarterly basis, Other Non Operating Income fell 94.11% year-over-year to $27236.0 in Q4 2025; TTM through Dec 2025 was $20242.0, a 95.38% decrease from a year earlier, with the FY2025 full-year figure at $20242.0, down 95.38% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $27236.0, up from -$10225.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for MNOV reached as high as $462050.0 in Q4 2024 and fell as low as -$463307.0 in Q1 2023.
- Historically, Other Non Operating Income has averaged -$17567.4 across 5 years, with a median of -$13562.5 in 2021.
- Across the five-year window, Other Non Operating Income tumbled 3270.98% in 2023 and surged 21111.82% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$14213.0 in 2021, then tumbled by 1270.09% to -$194731.0 in 2022, then soared by 98.87% to -$2199.0 in 2023, then jumped by 21111.82% to $462050.0 in 2024, then tumbled by 94.11% to $27236.0 in 2025.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $27236.0 in Q4 2025, -$10225.0 in Q3 2025, and $952.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Medicinova | 64.52 Mn | 64.52 Mn | 4,754.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,236.00 |
| Sep 30, 2025 | -10,225.00 |
| Jun 30, 2025 | 952.00 |
| Mar 31, 2025 | 2,279.00 |
| Dec 31, 2024 | 462,050.00 |
| Sep 30, 2024 | 9,102.00 |
| Jun 30, 2024 | -17,055.00 |
| Mar 31, 2024 | -16,035.00 |
| Dec 31, 2023 | -2,199.00 |
| Sep 30, 2023 | -14,153.00 |
| Jun 30, 2023 | -23,210.00 |
| Mar 31, 2023 | -463,307.00 |
| Dec 31, 2022 | -194,731.00 |
| Sep 30, 2022 | -8,472.00 |
| Jun 30, 2022 | -30,338.00 |
| Mar 31, 2022 | -13,744.00 |
| Dec 31, 2021 | -14,213.00 |
| Sep 30, 2021 | -13,381.00 |
| Jun 30, 2021 | -8,966.00 |
| Mar 31, 2021 | -22,938.00 |